Investment Management Corp of Ontario (IMCO)’s Teva Pharmaceuticals TEVA Stock Holding History

Investment Management Corp of Ontario (IMCO)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.46M	Sell	72,660 -7,900	-10%	-$263K	0.03%	377
2026 Q1	$2.43M	Sell	80,560 -21,488	-21%	-$691K	0.03%	385
2025 Q4	$3.18M	Buy	102,048 +49,788	+95%	+$1.23M	0.04%	342
2025 Q3	$1.06M	Buy	52,260 +25,700	+97%	+$451K	0.02%	468
2025 Q2	$445K	Sell	26,560 -3,700	-12%	-$59.7K	0.01%	541
2025 Q1	$465K	Buy	+30,260	New	+$541K	0.01%	546
2024 Q4	–	Sell	-36,560	Closed	-$659K	–	628
2024 Q3	$659K	Sell	36,560 -26,293	-42%	-$460K	0.01%	481
2024 Q2	$1.02M	Buy	62,853 +44,793	+248%	+$690K	0.03%	323
2024 Q1	$255K	Sell	18,060 -8,100	-31%	-$102K	0.01%	544
2023 Q4	$273K	Buy	+26,160	New	+$244K	0.01%	600

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Investment Management Corp of Ontario (IMCO)'s TEVA Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its Teva Pharmaceuticals (TEVA) stake by 9.8% in Q2 2026, selling an estimated $263K and leaving 72,660 shares worth $2.46M. The position accounts for 0.03% of the portfolio, ranked #377.

Investment Management Corp of Ontario (IMCO) first reported a position in TEVA in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.18M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Investment Management Corp of Ontario (IMCO) held 72,660 shares of Teva Pharmaceuticals worth $2.46M as of Q2 2026.
Investment Management Corp of Ontario (IMCO) sold 7,900 Teva Pharmaceuticals shares in Q2 2026, an estimated $263K.
Teva Pharmaceuticals made up 0.03% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #377 holding.
Investment Management Corp of Ontario (IMCO) first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Investment Management Corp of Ontario (IMCO)'s Teva Pharmaceuticals position peaked at $3.18M in Q4 2025.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.